- H1 2025 organic sales growth was 3.1%, with reported revenue at €2,554 million.
- EBITDA increased by 4.5% to €554 million, with a margin rise to 21.7%.
- Symrise targets €40 million in cost savings for 2025, achieving €20 million in H1.
- Net debt rose by €210 million to €2,046 million as of December 31, 2024.
Financial Performance
In the first half of 2025, Symrise reported organic sales growth of 3.1%, with total revenue reaching €2,554 million, considering portfolio and exchange rate effects. The company achieved an EBITDA of €554 million, marking a 4.5% increase from the previous year, and improved its EBITDA margin to 21.7%.
Segment Highlights
The Taste, Nutrition & Health segment saw organic sales growth of 3.3%, with reported revenue at €1,564 million. The Scent & Care segment achieved 2.9% organic sales growth, with revenue at €989 million. Both segments benefited from efficiency gains and improved input costs.
Cost Management and Savings
Symrise has set a target for €40 million in cost savings for 2025, having already achieved €20 million in the first half. The company continues to focus on efficiency improvements and profitable sales to enhance its financial performance.
Debt and Income
Net debt increased by €210 million to €2,046 million as of December 31, 2024. Including pension and lease liabilities, net debt amounted to €2,535 million. The company reported a consolidated net income of €268 million, up from €239 million in the same period of the prior year.
Outlook
Symrise has moderated its organic growth outlook to 3%-5% for 2025, while increasing its EBITDA margin target to approximately 21.5%. The company reaffirms its 2028 mid-term targets, aiming for 5%-7% organic growth and an EBITDA margin of 21%-23%.
